EC 618-415-6
Also known as alginate, alginic acid sodium salt, and E401.
Process development and GMP manufacturing of lactoperoxidase and glucose oxidase to support an IND filing and a Phase II clinical trial in the US.
The biorefinery will process invasive brown algae into sustainable ingredients, addressing environmental issues and offering alternatives to fossil-based chemicals.
The facility processes invasive algae into ingredients, bridging lab innovation to industrial scale, and sets the stage for a future biorefinery in Finland.
An impairment loss of PLN 36.8M was recorded due to halted steam supplies, affecting EBITDA and net results. Production stopped on Sept 18, 2019. Future decisions pending by year-end.
A subscription lists every plant we track for sodium alginate, with its owners and capacity. What a subscription does →
